Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine.
Lee
Jonathan
J
Franz
Lauren
L
Goforth
Harold W
HW
D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects; D001416:Back Pain / Q000150:complications / Q000188:drug therapy*; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000150:complications; D003920:Diabetes Mellitus; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008691:Methadone / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D020230:Serotonin Syndrome / Q000175:diagnosis*; D014202:Tremor / Q000139:chemically induced; D000069470:Venlafaxine Hydrochloride
D000701:Analgesics, Opioid; D000890:Anti-Infective Agents; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D002939:Ciprofloxacin; D000069470:Venlafaxine Hydrochloride; D008691:Methadone